PharmOut Revenue and Competitors
Estimated Revenue & Valuation
- PharmOut's estimated annual revenue is currently $12.9M per year.
- PharmOut's estimated revenue per employee is $201,000
Employee Data
- PharmOut has 64 Employees.
- PharmOut grew their employee count by 8% last year.
PharmOut's People
Name | Title | Email/Phone |
---|---|---|
1 | GMP Services Director | Reveal Email/Phone |
2 | Learning and Development Director | Reveal Email/Phone |
3 | Lead Consultant | Reveal Email/Phone |
4 | Architectural Graduate | Reveal Email/Phone |
5 | Architectural Graduate | Reveal Email/Phone |
6 | Senior Consultant | Reveal Email/Phone |
7 | Consultant | Reveal Email/Phone |
8 | Senior Consultant | Reveal Email/Phone |
PharmOut Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $118.6M | 590 | 5% | N/A | N/A |
#2 | $64.6M | 267 | N/A | N/A | N/A |
What Is PharmOut?
PharmOut is a single contact point for your next project, the largest specialised regulatory company in South East Asia working for both industry and regulatory agencies we can offer a one stop shop.. Our Architects, Engineers and GMP consultants are experienced at designing, building, validating and help operate Medical Device, Veterinary and Pharmaceutical manufacturers. By supplying Architecture, Project Management, Engineering, GMP and Validation services to PIC/S, TGA and FDA standards. PharmOut also offers a broad and extensive range of training services including GMP training, GLP training and Validation training. PharmOut is head-quartered in Melbourne, Australia. Read more at www.pharmout.net
keywords:N/AN/A
Total Funding
64
Number of Employees
$12.9M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.2M | 77 | 22% | N/A |
#2 | $15M | 284 | -4% | N/A |
#3 | $82.8M | 457 | N/A | N/A |
#4 | $75M | 562 | 2% | N/A |
#5 | $75M | 622 | 17% | N/A |